This invention is generally directed to access devices for introducing and/or delivering a medical article (such as, for example, a catheter, cannula, sheath, etc.) into a body space, such as, for example, an artery, vein, vessel, body cavity, or drainage site.
A preferred non-surgical method for inserting a catheter or vascular sheath into a blood vessel involves the use of the Seldinger or a modified Seldinger technique, which includes an access needle that is inserted into a patient's blood vessel. A guidewire is inserted through the needle and into the vessel. The needle is removed, and a dilator and sheath in combination or separately are then inserted over the guidewire. The dilator and sheath, together or separately, are then inserted a short distance through the tissue into the vessel, after which the dilator and guidewire are removed and discarded. A catheter or other medical article may then be inserted through the sheath into the vessel to a desired location, or the sheath may simply be left in the vessel.
A number of vascular access devices are known. U.S. Pat. Nos. 4,241,019, 4,289,450, 4,756,230, 4,978,334, 5,124,544, 5,424,410, 5,312,355, 5,212,052, 5,558,132, 5,885,217, 6,120,460, 6,179,823, 6,210,332, 6,726,659 and 7,025,746 disclose that physicians and other healthcare providers would prefer. Thus, there exists a need for an easier-to-use and safer vascular access device, especially one that would clearly and promptly indicate when a blood vessel has been punctured and one that would reduce accidental needle sticks and other attendant risks of over-wire vascular access.
The described embodiments involve several features for an access device useful for the delivery of a catheter or sheath into a space within a patient's body, such as, for example, a blood vessel or drainage site. Without limiting the scope of this invention, its more prominent features will be discussed briefly. After considering this discussion, and particularly after reading the Detailed Description of the Preferred Embodiments section below in combination with this section, one will understand how the features and aspects of these embodiments provide several advantages over prior access devices.
In one embodiment, an access device for placing a medical article within a body space includes a needle, a dilator, and a medical article. The needle can include an elongated needle body with a distal end and a hub from which the needle body extends. The elongated needle body can include at least one side fenestration and an outer diameter. The dilator can be slideably disposed on the needle body and include a dilator hub and an elongated dilator shaft that extends from the dilator hub. The dilator shaft can include at least one side fenestration in communication with the needle side fenestration. The dilator shaft can also include an inner diameter that is less than the outer diameter of the needle. The medical article can include a tubular section and a hub. The tubular section can be disposed on the dilator and define a space between the medical article and the dilator in communication with the needle side fenestration through the dilator side fenestration. At a least portion of the medical article can be configured to allow visual determination of the presence of a body fluid within the space.
In another embodiment an access device for placing a medical article within a body space can include a needle, a dilator, and a medical article. The needle can include an elongated needle body with a distal end and a hub from which the needle body extends. The dilator can be slideably disposed on the needle body and include a dilator hub and an elongated dilator shaft that extends from the dilator hub. The dilator shaft can include at least one side fenestration in communication with the needle side fenestration and a raised ridge through which the fenestration passes. The medical article includes a tubular section and a hub. The tubular section can be disposed on the dilator and define a space between the medical article and the dilator in communication with the needle side fenestration through the dilator side fenestration. At a least portion of the medical article can be configured to allow visual determination of the presence of a body fluid within the space.
In yet another embodiment, an access device for placing a medical article within a body space can include a needle, a dilator, and a medical article. The needle can include an elongated needle body with a distal end and a hub from which the needle body extends. The dilator can be slideably disposed on the needle body and include a dilator hub and an elongated dilator shaft that extends from the dilator hub to a distal end. The dilator shaft can include at least one side fenestration in communication with the needle side fenestration, and the dilator distal end can taper at approximately 30 degrees. The medical article includes a tubular section and a hub. The tubular section can be disposed on the dilator and define a space between the medical article and the dilator in communication with the needle side fenestration through the dilator side fenestration. At a least portion of the medical article can be configured to allow visual determination of the presence of a body fluid within the space.
In a further embodiment, an access device for placing a medical article within a body space can include a needle, a dilator, a sealing piece, and a medical article. The needle can include an elongated needle body with a distal end and a hub from which the needle body extends. The dilator can be slideably disposed on the needle body and include a dilator hub and an elongated dilator shaft that extends from the dilator hub to a distal end. The dilator shaft can include at least one side fenestration in communication with the needle side fenestration. The sealing piece can be slideably disposed on the needle body and be disposed between the dilator and the needle to inhibit fluid flow between the dilator and needle hubs. The medical article includes a tubular section and a hub. The tubular section can be disposed on the dilator and define a space between the medical article and the dilator in communication with the needle side fenestration through the dilator side fenestration. At a least portion of the medical article can be configured to allow visual determination of the presence of a body fluid within the space.
In another embodiment, a method of accessing a body cavity is provided. A needle with a hollow bore, a side fenestration, and a needle hub can be inserted into a body cavity. A dilator with a side fenestration and a dilator hub can be axially disposed on the needle and a medical article can be axially disposed on the dilator. A body fluid can be drawn from the body cavity through the needle bore to the needle side fenestration. Further, the body fluid can be drawn through the needle side fenestration and through the dilator side fenestration into a space between the dilator and the medical article. Movement of the body fluid proximally between the needle and the dilator hub can be inhibited.
In yet another embodiment an access device for placing a medical article within a body space can include a guidewire section, a needle, a dilator, and two locking mechanisms. The guidewire section can include a guidewire and a guidewire hub. The needle can be disposed on the guidewire and have an elongated needle body with a distal end and a hub from which the needle body extends. The dilator can be disposed on the needle body, the needle and the dilator being moveable relative to each other from a first position, wherein the distal end of the needle lies distal of the dilator, and a second position wherein the distal end of the needle lies within the dilator. The dilator can also include a dilator hub and an elongated dilator shaft that extends from the dilator hub. The first locking mechanism can operate between the needle and the dilator, and can include a portion spaced from the dilator that inhibits movement of the needle relative to the dilator when in the second position. The first locking mechanism can be configured to allow movement of the needle from the first position toward the second position without engagement by the locking mechanism so as to lessen resistance to the movement. The second locking mechanism can operate between the dilator and the guidewire, and can include a T-shaped locking section disposed on the guidewire that interengages with the guidewire hub to form a reversible snap-fit grip.
These and other aspects of the present invention will become readily apparent to those skilled in the art from the following detailed description of the preferred embodiments, which refers to the attached figures. The invention is not limited, however, to the particular embodiments that are disclosed.
These and other features, aspects, and advantages of the access device disclosed herein are described below with reference to the drawings of preferred embodiments, which are intended to illustrate and not to limit the invention. Additionally, from figure to figure, the same reference numerals have been used to designate the same components of an illustrated embodiment. Like components between the illustrated embodiments are similarly noted as the same reference numbers with a letter suffix to indicate another embodiment. The following is a brief description of each of the drawings.
The present disclosure provides an access device for the delivery of a medical article (e.g., catheter or sheath) to a blood vessel or drainage site.
The present embodiment of the access device is disclosed in the context of placing an exemplary single-piece, tubular medical article into a body space within a patient. Once placed, the tubular article can then be used to receive other medical articles (e.g., catheters, guidewires, etc.) to provide access into the body space and/or be used to provide a passage way for introducing fluids into the body space or removing (e.g., draining) fluids from the body space. In the illustrated embodiment, the tubular medical article is a sheath or catheter that is configured primarily to provide a fluid passage into a vein. The principles of the present invention, however, are not limited to the placement of single piece sheaths or catheters, or to the subsequent insertion of a medical article via the sheath or catheter. Instead, it will be understood by one of skill in this art, in light of the present disclosure, that the access device disclosed herein also can be successfully utilized in connection with placing one or more other types of medical articles, including other types of sheaths, fluid drainage and delivery tubes, and single or multi-lumen catheters directly in the patient or indirectly via another medical article.
For example, but without limitation, the access device disclosed herein can also be configured to directly or indirectly place central venous catheters, peripherally inserted central catheters, hemodialysis catheters, surgical drainage tubes, tear-away sheaths, multi-piece sheaths, scopes, as well as electrical conduit for wires or cables connected to external or implanted electronic devices or sensors. As explained above, the medical articles listed above may be directly placed in the patient via the dilator, needle, and guidewire of the access device or subsequently placed within the patient via a medical article that was placed within the patient via the dilator, needle, and guidewire of the access device.
Further, the embodiments disclosed herein are not limited to co-axial insertion of a single medical article. For example, two catheters may be inserted in the patient via an inserted sheath or a second catheter may be inserted in the patient via an inserted first catheter. Further, in addition to providing a conduit into the vessel or other body space, the medical article inserted via the dilator, needle, and guidewire can form a lumen that is in addition to the lumen(s) of the subsequently inserted medical article. One skilled in the art can also find additional applications for the devices and systems disclosed herein. Thus, the illustration and description of the access device in connection with a sheath (e.g., for micro puncture applications) is merely exemplary of one possible application of the access device.
Each of these components includes a luminal fitting at a terminal end or transition (i.e., a hub) and elongated structure that extends from the fitting. Thus, in the illustrated embodiment, the needle 22 includes a needle body 32 that extends distally from the needle hub 34, the dilator 24 includes a dilator shaft 36 that extends distally from a dilator hub 38, and the sheath 26 includes a sheath body 40 that extends distally from a sheath hub 42. The guidewire section 28 comprises a guidewire 44 and preferably a guidewire hub or cap 46. In the illustrated embodiment, the guidewire hub 46 is disposed on the proximal end of the guidewire 44; however, in other applications, the hub 46 can be disposed at a location between the ends of the guidewire 44.
The needle body 32 preferably has an elongated tubular shape having a circular, constant-diameter inner bore and a circular, constant-diameter exterior surface. In other embodiments, however, the needle body 32 can have other bore and exterior shapes (such as, for example, but without limitation, an oval cross-sectional shape). The interior or exterior of the needle can also include grooves or channels. The grooves or channels may guide fluids within the needle bore either around or to certain structures of the needle 22 or within the needle 22 (e.g., around the guidewire). In some embodiments, the grooves or channels may assist in maintaining a desired orientation of the needle 22 with respect to the dilator.
The needle body 32 has a sufficiently long length to access a targeted subcutaneous body space and has a sufficient gauge size to withstand the insertion forces when accessing the body space without causing undue trauma. For many applications, the needle body can have a length between 3-20 cm, and more preferably between 3-10 cm. For example, to access a body space (e.g., a vessel) in the thorax of an adult human, the needle body 32 preferably has a length of 7 cm or greater, and more preferably has a length of 9 cm or greater, and most preferably has a length of 9 to 10 cm. The size of the needle preferably is 18 gauge or smaller, and more preferably between 18-28 gauge, and most preferably between 18-26 gauge for micro-puncture applications (peripheral IVs). For applications with a neonate, the length and gauge of the needle body 32 should be significantly shorter and smaller, for example preferably between 3-4 cm and between 26-28 gauge.
As best seen in
As is illustrated in
The fin 58 also provides a grasping region to manipulate the needle hub 34. For example, a physician or healthcare provider can place an index finger and thumb on the sides of the fin 58 to stabilize the needle hub 34, relative to the dilator 24 and/or sheath 26. In the illustrated embodiment, as the dilator/sheath slides distally over the needle, the needle hub 34 slides relatively along the track 30 between a first position 121 and a second position 123 (example portions illustrated in
With specific reference now to
The locking structure on the proximal portion 52 of the needle hub 34 allows the physician or healthcare provider to secure another medical article to the proximal end of the needle hub 34. For example, the needle hub 34 in the illustrated embodiment includes an annular flange or lip 63. The lip 63 is threaded to allow the needle hub 34 to attach to other medical articles with a corresponding luer-nut locking feature. Additionally, a physician or healthcare provider may attach a syringe or monitoring equipment to the locking structure on the proximal end to perform other procedures as desired. The needle hub 34 can also include a septum at its proximal end and/or a side port if these features are desirably for a particular application.
The locking structure on the distal portion of the needle hub 34 allows the physician or healthcare provider, for example, to lock the needle hub 34 to the dilator hub 38 when the needle hub 34 is in the first position 121. In the illustrated embodiment, the locking structure includes a latch element 66 on the needle hub 34. The latch element 66 releasably locks the needle hub 34 to the dilator hub 38. The locking structure allows the healthcare provider to advance the needle into a patient while grasping the needle hub 34, the dilator hub 38 or both.
As explained below in greater detail, the guidewire 44 is introduced through a hollow portion 62 of the needle hub 34, through the needle body 32, and into a punctured vessel. The guidewire 44 allows the healthcare provider to guide the dilator 24 and sheath 26 into the vessel.
The needle hub 34 may also comprise two tangs 68 that allow the needle hub 34 to slide along the track 30 between a first position 121 and a second position 123. While in the preferred embodiment the two tangs 68 of the needle hub 34 are engaged with the track 30 between the first position 121 and the second position 123, in other embodiments the needle hub 34 is only engaged with the track 30 over a portion of the length of the track 30 between the first position 121 and the second position 123. The sliding interconnection between the track 30 and the needle hub 34 also can be accomplished using other cooperating structures (e.g., a corresponding pin and tail of dovetail connection).
The dilator hub 38 may comprise one or more vents. In the illustrated embodiments, the vents in the dilator hub 38 are formed by grooves 75. Additionally, the dilator shaft 36 may comprise one or more longitudinal channels formed in the outer surface of the dilator shaft 36. In the illustrated embodiment, the channel is an open channel. The side walls of the open channel are formed by ridges 76. In the illustrated embodiment, the ridges 76 define generally smooth, arcuate exterior surfaces that interface with the sheath 26; however, in other embodiments, the ridges can have other shapes (e.g., can define more pronounced apexes). Once assembled within a sheath body 40, the open channel in the dilator shaft 36 is closed by the inside diameter of the sheath body 40.
In the illustrated embodiment, the opening 74 in the dilator shaft 36 has an oblong shape with its major axis being non-parallel relative to the major axis of the oblong opening 56 in the needle 22. For example the needle opening 56 may extend in a longitudinal direction and the dilator opening 74 may extend in a circumferential direction or vice versa. In other words, the long axis of the dilator opening 74 is disposed generally perpendicular to the long axis of the needle opening 56. As explained in connection with additional embodiments below, these openings 56, 76 can have other shapes, sizes and orientations that preferably obtain a significant degree of overlap to account for manufacturing tolerances and rotational misalignments. For this reason, it is preferred that one of the fenestrations has a greater dimension in at least one direction than the other one of the fenestrations in the same direction. Accordingly, in the illustrated embodiment, the needle fenestration 56 has a longer longitudinal dimension than the longitudinal dimension of the dilator fenestration 74.
The channel formed between the ridges 76 extends in a proximal direction from a point distal to the opening 74. The ridges 76 in the illustrated embodiment are disposed along the dilator shaft 36 and on opposite sides of the dilator shaft 36 so as to balance the dilator shaft 36 within the sheath. In the illustrated embodiment, the ridges 76 form two channels there between. Balancing the dilator within the sheath allows the dilator to apply equal pressure to the inside circumference of the sheath.
The dilator hub 38 may include locking structures at the proximal region 72 and the distal region of the dilator 24. Each locking structure may be a luer type or other type of connection. In the illustrated embodiment, the dilator hub 38 comprises a first luer connection 78, a second luer connection 80, a lip 77, and a base 79. The first luer connection 78 engages to the needle hub 34 on the needle 22 illustrated in
The color of the dilator 24 may be selected to enhance the contrast between the blood or other fluid and the dilator 24. During blood flash, for example, blood is observed flowing between the dilator 24 and the sheath to confirm proper placement of the needle in a blood vessel. To increase the visibility of the fluid as the fluid flows between the sheath and dilator 24, the sheath is preferably manufactured from a clear or transparent material with the dilator 24 having a color that contrasts with the color of the fluid. For example, the dilator 24 may have a white color to enhance its contrast with red blood. Other colors of dilator 24 could be employed depending on the color of the fluid and the degree of contrast desired. Further, only a portion of the dilator in the region of the blood flash can have the contrasting color with the remainder having a different color. For embodiments that have a channel formed between the needle and dilator 24, the dilator 24 may be manufactured of a clear or transparent material similar to the sheath to allow the physician to observe the blood flash through both the sheath and dilator 24.
The dilator 24 or sheath 26 may separately, or together, form one or more passages to allow air or gas to escape or vent from between the dilator 24 and sheath 26 and/or between the needle and the dilator. The one or more passages may further be sized to inhibit the flow of a liquid, such as blood, while allowing air to pass therethrough. The one or more passages may be in the wall of the sheath 26, the sheath hub, the dilator hub 38, an exposed section of the dilator shaft, and/or formed between adjacent surfaces of the dilator 24 and sheath 26. For example,
In the illustrated embodiment, the one or more passages allow air to pass through the luer connection between the sheath and dilator hubs. In the illustrated embodiment, a distal end of the passage 75 is located on the distal side of the luer connection with the proximal end of the passage 75 being located on the proximal side of the luer connection.
The one or more passages may be sized to filter blood or other liquid or may include a filter or other structure that inhibits the passage of a liquid while allowing the passage of air. For example, the sheath itself may include one or more passages in the form of small openings, pores or porous material. Depending on the size of the one or more passages and the expected size of the fluid molecules and formed elements (e.g. red blood cells), the one or more small openings, pores or porous material in the sheath can form a porous vent that allows air to pass yet retain blood.
A method of manufacturing a ridged dilator will now be described. First, an extrusion process is used to create a long tubular body having one or more longitudinal grooves or channels on its outer diameter (OD) or within the substance of the dilator. The long tubular body exceeds the required length of a single dilator and preferably has a length that is many times greater than the length of a single dilator. A manufacturing die is employed in the extrusion process having geometry that reflects the desired geometry for the inside and outside diameters of the dilator and the thickness and circumferential span of the longitudinal grooves or channels or interior channels. In the illustrated embodiment of
With reference back to the illustrated embodiment, the extruded tubular body is cut to the appropriate length for a single dilator. In the preferred method, the two OD grooves extend for the entire length of the cut dilator.
A tipping process is then employed on an end of the cut dilator to reform the tip. An end of the cut dilator is forced into a die/mandrel having geometry that matches the desired geometry of the tip of the finished dilator. The desired geometry is selected depending on, for example, the inside diameter of the sheath. It is desirable for the sheath and dilator to form a close fit or seal near the tip to promote blood flow in the proximal direction up the channel formed between the grooved dilator and sheath. Preferably, the OD of the dilator in the tip region tapers in the distal direction.
When in the die/mandrel, thermal energy is applied to the tip to reform the tip to match the die/mandrel. The thermal energy may be applied by any known technique, including using radiant heating from an infrared or RF heat source. As part of the tipping process, the dilator in the tip region is reformed so that the grooves are essentially removed. With the grooves removed, the dilator is able to form the close fit or seal with the sheath near the tip. The grooves are maintained along the remainder of the dilator on the proximal side of the location where the tip of the sheath 26 sits on the dilator. After removal from the die/mandrel, the tip end of the dilator may be cleaned and cut as necessary to remove any manufacturing remnants.
The one or more fenestrations in the dilator is cut through the dilator near the tip region and in or near the groove. Each fenestration may be cut by any known means, including a drill or laser. Further, the cutting device may be moved with respect to the dilator or vice versa to achieve an oblong or other shape for the fenestration.
The end of the dilator opposite from the tip end can be flared to facilitate over molding the dilator hub onto the dilator.
The sheath body 40 may be a single piece sheath through which a catheter or other medical article (e.g., a guidewire) is inserted into the vessel. In such an embodiment, the sheath body 40 forms a conduit for insertion of the catheter or other medical article (e.g., a guidewire). In addition to providing a conduit, the sheath or a portion of the sheath can form a lumen that is in addition to the lumen(s) of the catheter. For example, an equivalent to a triple lumen catheter can be formed by inserting a dual lumen catheter through the sheath body 40 with the sheath body 40 itself forming a third lumen.
It may be advantageous to remove a portion or the entire sheath body 40 depending on the type of catheter or medical article that is to be inserted into the vessel after employing the access device 20. For example, after the catheter or other medical article is inserted into the vessel, a portion of the sheath body 40 can be separated or peeled-away and removed. A peel-away sheath can include perforations, serrations, skives, or other structures, or include other materials (e.g., PTFE with bismuth) to allow the physician or healthcare provider to remove easily a portion or the entire sheath body 40.
The sheath hub 42 may include a luer slip connection and a lock member 94. The locking member 94 may comprise a locking or attaching structure that mates or engages with a corresponding structure. For example, the lock member 94 can be a luer connection 94 which can be configured to engage with the second luer connection 80 of the dilator hub 38.
The sheath hub 42, as best seen in
In some embodiments, the sheath hub 42 can comprise a lip 95. The lip 95 can be threaded to allow the sheath hub 42 to attach to other medical articles with a corresponding locking feature.
The sheath hub 42 preferably comprises one or more surface features to allow the physician or healthcare provider to easily grasp or manipulate the sheath 26 and/or access device 20. In the illustrated embodiment, the sheath hub 42 includes a squared grip 96 and ridges 98.
In additional embodiments, the sheath hub 42 may comprise radially extending wings or handle structures to allow for easy release and removal of the sheath body 40 from other parts of the access device 20. In some applications, the wings are sized to provide the healthcare provider with leverage for breaking apart the sheath hub 42. For example, the sheath hub 42 may comprise a thin membrane connecting the halves of the sheath hub 42. The membrane is sized to keep the halves of the sheath hub 42 together until the healthcare provider decides to remove the sheath hub 42 from the access device. The healthcare provider manipulates the wings to break the membrane and separate the sheath hub 42 into removable halves.
In some embodiments, the guidewire 44 may form a close fit with the inside diameter of the needle body so as to provide a self-aspirating function when retracted. For example, an outside diameter of the guidewire 44 may be selected to form a close fit with the needle along the length of the guide wire or along only a portion of the guidewire 44.
In some embodiments, the distal end portion of the guidewire can have a reduced diameter in comparison to other sections of the guidewire. The size of such reduced diameter section can be selected to permit fluid to pass to the fenestration 56 in the needle body even when the guidewire has been advanced beyond the distal tip of the needle.
The track 30 may further include a track section 132 of reduced width as shown most clearly in
As illustrated in
In the illustrated embodiment, the locking mechanism between the needle hub and the dilator resides on the proximal side of the dilator hub. In other embodiments, however, the locking mechanism can be disposed at other locations as well. For example, where the locking mechanism includes two pivotal levers which are joined by a locking hinge, the locking mechanism can be disposed radially relative to the needle hub. In such an embodiment, one lever is pivotally coupled to the dilator and the other lever is pivotally coupled to the needle. When the needle hub is moved away from the dilator hub, the levers straighten to a point where the hinge locks. A similar effect can be obtained by a tether limiting proximal movement of the needle hub relative to the dilator beyond a particular point, thereby locking the components together. In a further embodiment, an elongated structure can extend parallel to the needle body from the needle hub within the dilator. Once the needle hub is moved a sufficient distance away from the dilator, additional structure of the locking mechanism (e.g., a detent) engages the elongated structure to inhibit further movement of the needle relative to the dilator. Accordingly, as illustrated by these additional embodiments, the locking mechanism operating between the needle and the dilator can be disposed at a variety of locations relative to the dilator hub.
In the preloaded-state illustrated in
In the pre-loaded state, the dilator hub 38 is secured to the sheath hub 42. This can inhibit at least unintentional rotational and axial movement between the dilator 24 and the sheath 26. In embodiments where the sheath hub 42 and the dilator 24 have only a luer slip connection, the dilator 24 and sheath hub 42 may rotate relative to each other.
As noted above, the needle body 32 comprises one or more side openings 56 in its side wall. The dilator shaft 36 comprises one or more side openings 74. The side openings 56, 74 may have the same or different shapes as well as aspect ratios. In the illustrated embodiment, the side opening 56 in the needle body 32 has a different aspect ratio than the side opening 74 in the dilator shaft 36. The side opening 56 in the needle body 32 is elongated in one direction (e.g., substantially parallel to the longitudinal axis of the needle body 32). The side opening 74 in the dilator shaft 36 is elongated in a different direction (e.g., along the circumference of the dilator shaft 36). Having offset elongated openings 56, 74 in the needle body 32 and the dilator shaft 36 increases the likelihood that the openings 56, 74 in the needle body 32 and dilator shaft 36 will be sufficiently aligned so that blood flows through the needle side opening 56 and dilator side opening 74.
In the illustrated embodiment, the dilator shaft 36 is coaxially positioned to minimize an annular space 150 between the needle body 32 and the dilator shaft 36. The inner surface 152 of the dilator shaft 36 need not, though it can, lie directly against the outer-surface 154 of the needle body 32. Preferably, in this embodiment, the annular space 150 between the outer-surface 154 of the needle body 32 and the inner surface 152 of the dilator shaft 36 is minimized to inhibit the flow of blood or its constituents (or other bodily fluids) into the annular space 150 between the dilator shaft 36 and needle body 32. Advantageously, this feature minimizes the blood's exposure to multiple external surfaces and reduces the risk of contamination, infection, and clotting.
As illustrated in
The sheath body 40, as noted previously, is preferably made partially or completely from clear, semi-opaque, translucent, or transparent material so that when blood flows into the needle body 32, (1) through the needle side opening 56, (2) through the dilator side opening 74, and (3) into a channel 156, the physician or healthcare provider can see the blood. In some modes, the channel 156 is formed between the dilator shaft 36 and the sheath body 40 and defined by one or more ridges 76 on the dilator shaft 36. In some modes, the channel 156 is formed within a wall of the dilator shaft 36 with the dilator shaft 36 preferably comprising a transparent material. Blood will indicate to the physician or healthcare provider that the bevel tip 54 of the needle body 32 has punctured a vessel 148.
In some embodiments, the needle body 32 and dilator shaft 36 may (both) have multiple side openings where some or all of these side openings can be rotationally aligned.
The channel 156 can have an axial length that is almost coextensive with the length of the sheath 26. In other embodiments, the channel 156 can be significantly smaller than the elongated channel 156 just described. For example, but without limitation, the channel 156 can be disposed within a distal, mid and/or proximal portion(s) of the sheath 26. The channel 156 alternatively can have a linear, curved or spiral shape along an axial length of the sheath 26 or can be formed by a plurality of such shapes. The channel 156 may have various thicknesses and span angles. The thickness of the channel 156 can range from almost close to zero to 0.010 inches. Preferably, the channel 156 has a thickness of about 0.0005 to about 0.003 inches. More preferably, the channel 156 can have a thickness of about 0.001 inches to about 0.002 inches. The channel 156 can have a span angle Φ about the axis of the dilator 24 of about 30 degrees to about 210 degrees or more, but preferably less than 360 degrees. More preferably, the channel 156 can have a span angle Φ of about 60 to 150. In the illustrated embodiment, the channel 156 spans 120 degrees. The thickness and span angle Φ can be chosen so as to optimize the capillary action that occurs within the channel 156 as fluid (e.g., whole blood) enters the channel 156 as may further be selected based on the expected pressure in the body cavity and viscosity of the liquid.
The shape of the channel 156 described above and the resulting capillary action was optimized for use with whole blood as opposed to other fluids having a different viscosity than whole blood (e.g. leukocytes, pus, urine, plasma). However, the shape of the channel 156 is not limited to the disclosed shape and may be optimized for draining other liquids, such as pus. Further, the shape of the channel 156 described above was optimized for peripherally located vessels where the pressure in the vessel enhances the capillary action and resulting blood flash as well as for vessels located in the regions where the pressure may be low. For example, in the thorax region of the body, the expected pressure in the veins may be lower than in a peripherally located vein when the patient breathes. A different size of the channel for use of the access device 20 in other regions of the body may be employed taking into account the expected pressure within the vessel or body cavity.
Additionally, an outer-surface 160 of the dilator shaft 36 and/or an inner surface 158 of the sheath body 40 can be coated with a substance to promote or enhance the capillary action within the channel 156. For example a hydrophilic substance can be used to coat outer-surface 160 of the dilator shaft 36 and/or the inner surface 158 of the sheath body 40 to enhance capillary action. As another example, a surfactant can be used to coat the outer-surface 160 of the dilator shaft 36 and the inner surface 158 of the sheath body 40. One example of a surfactant that can be used is Lutrol68â„¢, commercially available from BASFâ„¢; other surfactants can also be used. Other surfaces that can be coated include the inner surface of the needle body 32, the outer surface 154 of the needle body 32, the inner surface 152 of the dilator shaft 36, and the guidewire 44. These surfaces, including the outer-surface 160 of the dilator shaft 36 and the inner surface 158 of the sheath body 40, can be coated with a surfactant individually, or in combination. In the embodiments described above it may be preferable to coat both the outer-surface 160 of the dilator shaft 36 and the inner surface 158 of the sheath body 40 to promote or enhance progression of a body fluid through the channel 156. However, in some embodiments it may be preferable to only coat one of these two surfaces with a surfactant.
Use of a surfactant can accelerate and facilitate the progression of blood through the needle, dilator, or sheath. Accordingly, smaller needles, dilators, and sheaths can be used while still allowing blood to travel through said pieces with sufficient speed to indicate to an operator that the needle has entered the vessel or drainage site. Notably, in most embodiments a body fluid will pass through the needle, and thus in most embodiments it can be desirable to apply a surfactant to the interior surface of the needle.
Similarly, one or more of these components can be made of a hydrophilic material. A hydrophilic substance additionally can be applied to the outer surface of the sheath 26 to act as a lubricant to ease insertion of the sheath 26 into a patient. Other lubricants or lubricous coatings can be used on the exterior of the sheath 26 or at least the outer surface of the sheath can be formed of a lubricous material. Additionally, the sheath 26 can be coated or formed with agents (e.g., heparin), which elute from the sheath, to facilitate the clinical application of the access device 20. In one example, the outer surface of the sheath 26 can include a coating of silicone, such as Dow Corning 360 Medical Fluid, 12,5000 CSTâ„¢, commercially available from Dow Corning. Similarly, the sheath can be coated with a surfactant in some embodiments.
The dilator shaft 36 may be releasably mounted to the needle body 32 so that the dilator shaft 36 can be mounted and released, or vice versa, from a coaxial position relative to the needle body 32. This locking mechanism can inhibit at least some unintentional rotational and axial movement between the needle 22 and the dilator 24 when the needle hub 34 is in the first position. As shown, the needle hub 34 may have a luer connection 64 that locks to the luer connection 78 of the dilator hub 38. Furthermore, the needle hub 34 may also have latch element 66 that locks to the opening 82 in the dilator hub 38.
In addition,
As noted above, having openings 56, 74 in the needle body 32 and dilator shaft 36 with different aspect ratios will increase the likelihood that the openings 56, 74 in the needle body 32 and dilator shaft 36 will be aligned so that blood flows substantially unobstructed through the needle side opening 56 and dilator side opening 74.
In the following embodiments, structure from one embodiment that is similar to structure from another embodiment share the same root reference number with each embodiment including a unique suffix letter (32, 32A, 32B, etc.).
As noted above, the dilator shaft 36 may have one or more channels 156 formed between ridges 76 to form a conduit or flow path between the sheath body 40 and the dilator shaft 36 to enable the physician or health care provider to view the blood after the bevel tip 54 of the needle body 32 has properly punctured a vessel or the channels may be formed without ridges but by extruding axial indentations of various possible configurations or by forming fully enclosed channels within the dilator shaft or body.
In another mode, the access device includes a blood flash-back space defined between the shaft of the needle and the shaft of the dilator. In this mode, the flash-back space preferably vents to the atmosphere and more preferably vents independent of the sheath. In particular, as described below, a vent passage is formed through the dilator, through the needle, or between the dilator and the needle.
As best shown in
In some embodiments, the venting grooves 175 can form a passage sufficiently small in cross-sectional area to allow the escape of gases (e.g., air) to the ambient atmosphere while hindering the escape to the ambient atmosphere of body liquids (e.g., red blood cells) with high molecular sizes, viscosities, or surface tensions. Further, in some embodiments multiple such passages can be provided, allowing adequate air ventilation despite small cross-sectional passages.
In other embodiments, the small cross-sectional area of the passage can be provided between two opposing surfaces of the dilator hub 38G and the needle hub 34G. For example, at least a portion of the venting groove 175 on the needle hub 34G can be configured to receive a generally correspondingly shaped venting surface on the dilator hub 38G without entirely blocking the venting groove. The resulting passage between the surfaces of the needle hub 34G and the dilator hub 38G thus define at least a region of relatively small cross-sectional area to permit air flow but restrict the flow of bodily fluids.
While the venting structure is depicted as grooves 175 in the illustrated embodiment, other structures can perform similar functions. For example, a single reduced space location between the needle body 32G and the dilator body 34G can permit the escape of air while inhibiting the flow of blood proximally beyond the reduced space location. Similarly, a labyrinth passage can be disposed between the ambient atmosphere and the flash-back space (the space between the needle and dilator).
In other embodiments, one or more of the venting grooves 175 can be filled at least in part by a porous material that permits gases to flow through the material but inhibits the passage of a body fluid (e.g., blood). Such material can be integrally formed into the needle hub 34G or dilator hub 38G such that the material and the hubs are unitary. The material can then comprise any portion of the length of the venting grooves 175. In other embodiments the material can be placed into the venting grooves 175 or a receptacle in communication with the groove(s). When the material is placed into the groove 175, the groove can include a receiving portion such as a groove notch 185 configured to receive the porous material. One or more of the vent passages in other embodiments can be entirely formed by such porous material. Suitable porous materials include, but are not limited to a porous polymer such as HDPE, UHMWPE, PP, PTFE, PVDF, EVA, PE, Nylon, and PU, of pore size approximately 2.5 microns. In further embodiments, a combination of pore volume and pore size can be chosen to allow passage of gases (such as air) but inhibit the passage of body fluids (such as blood).
In further embodiments, the venting passages can be tubes defined solely by either the needle hub 34G or the dilator hub 38G. For example, the channel 256 can lead to an opening in the needle hub 34G. This opening can include any of the characteristics discussed above to control the passage of gases and fluids. The opening can thus allow the escape of gases (e.g. air) through the needle hub 34G to the ambient atmosphere while inhibiting the passage of body fluids (e.g. blood). In other embodiments, a similar venting passage can be a tube defined solely by the dilator hub 38G. It will be clear from the disclosure herein that a variety of passages (e.g. venting grooves 175, tubes, porous material, etc.) can be used to allow the escape of gases (e.g. air) to the ambient atmosphere while inhibiting the escape of body fluids (e.g. blood).
In another embodiment, the venting passages can be within the dilator shaft 36G and the sheath body 40. For example, a venting hole or a patch of venting material can be provided in each of the dilator shaft 36G and the sheath body 40. In some embodiments these venting structures can overlap, allowing gases to pass directly from one to the other. In other embodiments, these venting structures can be positioned some distance away from each other, in which case a channel or groove similar to those in
As shown, the dilator shaft 36G in this embodiment can have no fenestration and can be generally continuous. The dilator shaft 36G can thus radially close the channel 256 (or similar space). In similar embodiments the same functionality can be accomplished with ridges in the dilator shaft 36G cooperating with an otherwise generally continuous needle 32G including a fenestration 56. The dilator shaft 36G can be formed of a translucent material in the entirety, or alternatively be translucent in at least the region adjacent the channel 256. The sheath body 40 can be similarly formed of a translucent material. In other embodiments, the material can be transparent instead of only translucent. In further embodiments, the material can be only partially translucent both spatially and temporally. Spatially, the material of the dilator shaft 36G and/or the sheath body 40 can be translucent near the channel 256, allowing visual confirmation of e.g. blood flash-back. Temporally, the visual characteristics of the material can change upon entry of a body fluid (e.g. due to temperature change or molecular interaction). The material can thus become translucent upon entry of a body fluid, or in other embodiments change color or provide some other visual indication.
Further, the access device depicted in
In other embodiments, the channel 156 can be formed by having one complete ridge on the inner surface of the sheath and one complete ridge on the outer surface of the dilator. In other embodiments, the inner surface of the sheath can have two ridges that run 50% of the length of the channel 156 and the outer surface of the dilator can have two ridges that run the remaining 50% of the channel 156.
In even further embodiments, the venting can be provided at least partially through an insert 451 between a dilator hub 438 and needle hub 434, as best shown in
The embodiment depicted in
As best depicted in
Even further, the insert 451 can have particular dimensions to facilitate the release of gases while hindering the release of body fluids. For example, the diameter of the insert's through-hole 452 can be only slightly greater than the outer diameter of the needle body 432, creating a space that allows the release of gases but hinders the release of a body fluid. As best shown in
Further, the outer edge of the insert 451 can be shaped to substantially match the receiving portion of the receiving portion of the dilator hub 438 to form a seal between the two that at least hinders the escape of a body fluid therethrough. In some embodiments, a taper within the dilator hub 438 (also used for a luer connection with a needle, as discussed above) can facilitate a seal between the insert 451 and the dilator hub. In some embodiments, the seal between the outer edge of the insert 451 and the receiving portion 460 of the dilator hub 438 can also be impermeable to gases, forcing their passage through the through-hole 452, as described above.
During assembly, when the insert 451 is inserted into the dilator hub 438, the insert can sometimes enter slightly off-angle from the receiving portion and thus be stuck slightly ajar. Due to the size of the pieces and the depth of the receiving portion 460, it may be difficult to detect when the insert 451 is ajar. Thus, the insert 451 can be configured to provide tolerances for such off-angle insertion. For example, as depicted the through-hole 452 can include a proximally-tapered portion 453. The proximally tapered portion 453 can help preserve a venting space between the needle body 432 and the insert 451 through which gases can escape but the escape of a body fluid can be hindered.
The insert 451 can also include a proximally projecting portion depicted as a ridge 455 along its proximal face, which can be of particular relevance as shown in
In other embodiments, the proximally projecting portion on the insert 451 can take other forms. For example, in some embodiments the insert 451 can have one or more distinct projections to maintain separation from the needle hub 434. In further embodiments, the insert 451 can include one or more grooves that allow the escape of gases despite contact with the needle hub 434. Even further, in some embodiments similar structures can be provided on the needle hub instead of or in addition to the structures on the insert.
With reference to
The sealing portion 250 can take a variety of cross-sectional shapes, including triangular (an example of which is illustrated in
As further depicted in
When the needle is withdrawn into the dilator and locked therein, the distal end of the needle can lie to the proximal side of the sealing portion 250 in some embodiments, and can lie to the distal side of the sealing portion 250 in other embodiments. In either position, the absence or the reduction of fluid on proximal side of the seal lessens the amount of body fluid flowing through the dilator hub once the dilator has been withdrawn from the patient's body.
The sealing portion 250 can be formed on the dilator in any of a wide variety of ways readily known to those skilled in the art. For example, in some embodiments, the sealing portion 250 can be formed during a dilator tipping process after the dilator has been extruded. An internal mandrel can be cut with an annular groove that has the inverse image of the sealing portion 250. The mandrel is then placed within dilator. As the material of the dilator's distal end is heated during the tipping process and then pressed into the desired exterior shape, the material will also be forced into the annular groove on the mandrel to form the sealing portion 250. After sufficient cooling, the dilator can be withdrawn.
In other embodiments, a sealing portion can take a different form. For example, a needle can have an expanded exterior portion, forming an enlarged external diameter on the proximal side of its fenestration, similar to the enlarged internal diameter of the expanded portion 260 of the embodiment depicted in
As additionally indicated in
In some embodiments, the inner diameter d1 of the dilator 24H can be smaller than the outer diameter d2 of a needle on which it mounts by approximately 15% or less. In other words, the outer diameter d2 of the needle can be approximately 15% larger than the inner diameter d1 of the dilator 24H. In more preferred embodiments, the inner diameter d1 of the dilator 24H is smaller than the outer diameter d2 by approximately 10% or less. In even more preferred embodiments, the inner diameter d1 is smaller than the outer diameter d2 by approximately 2% to 4% of the outer diameter d2. In particularly preferred embodiments, the inner diameter d1 of the dilator 24H can be approximately 97% of the outer diameter d2 of a needle on which it mounts.
Further, as depicted in
Additionally, as depicted in
In some embodiments a needle with an echogenic portion 270 can further lack fenestrations 56, 74, grooves 75, and/or surfactant. Further, in some embodiments with an echogenic portion 270, the access device can lack a flashback space or flash chamber.
In other embodiments, the needle 22J can have both an echogenic portion 270 and a fenestration 56 (in addition to other optional features described above). Further, in other embodiments, the needle 22J can include a contrast portion 280. The contrast portion 280 can have optical properties that improve the visibility of a fluid surrounding the contrast portion. For example, as described above, in some embodiments a body fluid can flow into a flashback space through the fenestration 56. The contrast portion 280 can then be positioned generally adjacent the flashback space and the contrast portion can have optical properties that contrast with the body fluid. Thus, the body fluid's entry into the flashback space can be more immediately apparent.
For example, in embodiments where the fluid entering the flashback space is a body fluid such as blood, the contrast portion 280 can have a color that contrasts with the color of blood, such as white, green, blue, etc. In further embodiments, other optical properties can be varied such as by choosing between a reflective or matte finish. In other embodiments, the contrast portion 280 can have be striped, checkered, dotted, or have some other pattern wherein the optical properties vary. For example, the contrast portion 280 can have black and white stripes oriented axially and/or circumferentially along the needle. Where a pattern with different optical properties is utilized, the contrast portion 280 can be more generic to different fluids that may be distinguishable from one region of the contrast portion 280 but not another region.
The varying optical properties can be applied in a variety of ways. For example, in some embodiments the contrast portion 280 can be painted to have a particular color, finish, pattern, etc. In other embodiments, portions of the needle can be polished or roughened to effect the reflective properties of the contrast portion 280. In even further embodiments, the contrast portion 280 can be formed from a different material, or have a different material applied to its surface, to yield different optical properties. Even further, in some embodiments the contrast portion 280 can be made echogenic, as in the echogenic portion 270 described above.
As depicted in
In embodiments where the flashback space occurs between a dilator and a sheath (as described above), the dilator can have corresponding portions that are clear, translucent, transparent, or semi-opaque, such that the contrast portion 280 can be viewable from outside the access device. Then, as a fluid such as a body fluid enters the flashback space an observer can see both the contrast portion 280 and the body fluid as it enters the flashback space to occlude the contrast portion 280. The contrast in optical properties between the fluid and the contrast portion 280 can then facilitate the visual detection of the fluid's entry.
Additionally, in such embodiments where the flashback space occurs between the dilator and the sheath, the flashback can be enhanced or accelerated by sealing off or restricting air flow from the space between the needle body and the dilator body. In a preferred embodiment, fluid leakage (e.g., air egress) between a dilator and sheath can be reduced by placing a sealing piece such as a washer between the needle and dilator hubs. The washer reduces any fluid flow that might occur between a dilator and needle at their abutting hubs. Thus, a trapped air column can form between the dilator and needle that inhibits the flow of a body fluid (e.g., blood) into the space between the needle and dilator. The body fluid flow can thus be diverted, e.g., into a dilator fenestration 74H and into a space between a dilator and sheath. In some embodiments, the washer can be an elastic material, such as silicone. The washer can mount on the needle and have a planar or an o-ring-like shape.
This concept can also be applied to other embodiments. For example, in some embodiments a flashback space can be provided between a needle and a dilator. As between the dilator and the sheath, as discussed above, a channel can be formed between the needle and the dilator that can receive blood or other fluids through the needle fenestration 56. An example of such a flashback space is described in
Thus, in some embodiments a preassembled access device can optionally be provided with a needle 22J that does not include any fenestrations and that can (but need not) be echogenic (depicted in
In some embodiments, an access device can also include a modified track 30K and guidewire hub 46K, as depicted in
A corresponding guidewire hub 46K can have corresponding structure with the coupling section 290 to releasably connect thereto. As depicted, the guidewire hub 46K can include a receiving section 296 that can be in the form of a recess. The recess can have a T-shaped cross-section at a proximal end to match the coupling section 290, as best depicted in
Additionally, in the depicted embodiment of the track 30K, the track can include a grip projection 294. The grip projection 294 can extend downward from the track 30K, opposite from the coupling section 290. As depicted, the grip projection 294 can be generally circular with gripping ridges, but other structures and shapes are possible. Advantageously, the grip projection 294 can allow an operator of the access device to hold the proximal end of the track 30K in a pistol-type grip. For example, a ring finger or middle finger can be positioned around the grip projection 294 to contact it on the distal side. The thumb of the same hand can then be placed on the proximal end of a guidewire hub 46K coupled in the third position 125K. The thumb can then easily apply pressure to move the hub 46K off of the coupling section 290 and out of the third position 125K. A similar grip projection can be applied to other tracks, such as the track 30 described above. Further, similar grip projections can be applied to other elements, such as a needle. Applying a grip projection to the needle can, for example, allow a needle to be easily gripped and moved along a track as described herein.
In some further embodiments, a modified sheath 26L, with some similarities to the previous sheaths discussed, can be combined with the other element described. As depicted in
The sheath hub 42L can additionally include a ridge 325 toward a distal end of the hub. The ridge 325 can facilitate gripping of the hub 42L. Additionally, in some embodiments the ridge 325 can receive a tubular or cylindrical cover that can extend over the distal portions of the sheath, dilator, and needle to protect the tip, and press onto the ridge 325. Thus, the ridge 325 can hold the cover in place.
The embodiments herein described are comprised of conventional, biocompatible materials. For example, the needle preferably consists of ceramic, a rigid polymer, or a metal such as stainless steel, nitinol, or the like. The other elements can be formed of suitable polymeric materials, such as polycarbonate, nylon, polyethylene, high-density polyethylene, polypropylene, fluoropolymers and copolymers such as perfluoro (ethylene-propylene) copolymer, polyurethane polymers or co-polymers. For example, in some embodiments the dilator can be formed from nylon.
As noted above, the present access device can be used to place a catheter at other locations within a patient's body. Thus, for example, but without limitation, the access device can be used as or with a variety of catheters to drain fluids from abscesses, to drain air from a pneumothorax, and to access the peritoneal cavity. In such applications, body fluids flow into the viewing space to indicate when the needle has been properly placed.
Although this invention has been disclosed in the context of certain preferred embodiments and examples, it will be understood by those skilled in the art that the present invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. In addition, while a number of variations of the invention have been shown and described in detail, other modifications, which are within the scope of this invention, will be readily apparent to those of skill in the art based upon this disclosure. It is also contemplated that various combinations or sub-combinations of the specific features and aspects of the embodiments may be made and still fall within the scope of the invention. Accordingly, it should be understood that various features and aspects of the disclosed embodiments can be combined with or substituted for one another in order to form varying modes of the disclosed invention. For example, the general shape of the needle hub depicted in
This application is a continuation of U.S. patent application Ser. No. 16/191,122, filed Nov. 14, 2018, which is a divisional of U.S. patent application Ser. No. 14/589,702, filed Jan. 5, 2015, now issued as U.S. Pat. No. 10,136,916, which is a continuation of U.S. patent application Ser. No. 13/577,653, filed Aug. 7, 2012, now issued as U.S. Pat. No. 8,956,327, which is a national stage entry of International Patent Application No. PCT/US2011/024097, filed Feb. 8, 2011, which claims the priority benefit under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application No. 61/302,486, filed Feb. 8, 2010, the entirety of which is hereby expressly incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
500740 | Doyle | Jul 1893 | A |
1436882 | Knepper | Nov 1922 | A |
3185152 | Ring | May 1965 | A |
3539034 | Tafeen | Nov 1970 | A |
3540447 | Howe et al. | Nov 1970 | A |
3565074 | Foti et al. | Feb 1971 | A |
3670729 | Bennett et al. | Jun 1972 | A |
3680562 | Wittes | Aug 1972 | A |
3993079 | Gatztanondo | Nov 1976 | A |
3995628 | Gula et al. | Dec 1976 | A |
1052989 | Kline | Oct 1977 | A |
4068659 | Moorehead | Jan 1978 | A |
4068660 | Beck | Jan 1978 | A |
4072146 | Howes | Feb 1978 | A |
4170993 | Alvarez | Oct 1979 | A |
4180068 | Jacobsen et al. | Dec 1979 | A |
4191186 | Keeler | Mar 1980 | A |
4192305 | Seberg | Mar 1980 | A |
4205675 | Vaillancourt | Jun 1980 | A |
4230109 | Geiss | Oct 1980 | A |
4230123 | Hawkins, Jr. | Oct 1980 | A |
4233974 | Desecki et al. | Nov 1980 | A |
4274408 | Nimbrod | Jun 1981 | A |
4333505 | Jones et al. | Jun 1982 | A |
4345596 | Young | Aug 1982 | A |
4411655 | Schreck | Oct 1983 | A |
4412832 | Kling et al. | Nov 1983 | A |
4417886 | Frankenhouser et al. | Nov 1983 | A |
4445893 | Bodicky | May 1984 | A |
4512351 | Pohndorf | Apr 1985 | A |
4525157 | Vaillancourt | Jun 1985 | A |
4539003 | Tucker | Sep 1985 | A |
4581019 | Curelaru et al. | Apr 1986 | A |
4610665 | Matsumoto et al. | Sep 1986 | A |
4629450 | Susuki et al. | Dec 1986 | A |
4652256 | Vaillancourt | Mar 1987 | A |
4655750 | Vaillancourt | Apr 1987 | A |
4661300 | Daugherty | Apr 1987 | A |
4752292 | Lopez et al. | Jun 1988 | A |
4772264 | Cragg | Sep 1988 | A |
4791937 | Wang | Dec 1988 | A |
4826486 | Palsrok et al. | May 1989 | A |
4850960 | Grayzel | Jul 1989 | A |
4850975 | Furukawa | Jul 1989 | A |
4869259 | Elkins | Sep 1989 | A |
4894052 | Crawford | Jan 1990 | A |
4917669 | Bonaldo | Apr 1990 | A |
4917679 | Kronner | Apr 1990 | A |
4944728 | Carrell | Jul 1990 | A |
4950252 | Luther et al. | Aug 1990 | A |
4952207 | Lemieux | Aug 1990 | A |
4955890 | Yamamoto et al. | Sep 1990 | A |
4961729 | Vaillancourt | Oct 1990 | A |
4963306 | Weldon | Oct 1990 | A |
4978334 | Toye et al. | Dec 1990 | A |
4995866 | Amplatz et al. | Feb 1991 | A |
4997421 | Palsrok et al. | Mar 1991 | A |
5045065 | Raulerson | Sep 1991 | A |
5049136 | Johnson | Sep 1991 | A |
5053017 | Chamuel | Oct 1991 | A |
5059186 | Yamamoto et al. | Oct 1991 | A |
5064414 | Revane | Nov 1991 | A |
5066284 | Mersch et al. | Nov 1991 | A |
5067945 | Ryan et al. | Nov 1991 | A |
5098389 | Cappucci | Mar 1992 | A |
5098392 | Fleischhacker et al. | Mar 1992 | A |
5102394 | Lasaitis et al. | Apr 1992 | A |
5105807 | Kahn et al. | Apr 1992 | A |
5108374 | Lemieux | Apr 1992 | A |
5112308 | Olsen et al. | May 1992 | A |
5114401 | Stuart et al. | May 1992 | A |
5135502 | Koenig, Jr. et al. | Aug 1992 | A |
5135505 | Kaufman | Aug 1992 | A |
5158544 | Weinstein | Oct 1992 | A |
5167637 | Okada et al. | Dec 1992 | A |
5171218 | Fonger et al. | Dec 1992 | A |
5215525 | Sturman | Jun 1993 | A |
5215528 | Purdy et al. | Jun 1993 | A |
5242410 | Melker | Sep 1993 | A |
5242414 | Fischell et al. | Sep 1993 | A |
5242427 | Bilweis | Sep 1993 | A |
5246426 | Lewis et al. | Sep 1993 | A |
5248306 | Clark et al. | Sep 1993 | A |
5250038 | Melker et al. | Oct 1993 | A |
5255691 | Otten | Oct 1993 | A |
5279590 | Sinko et al. | Jan 1994 | A |
5295969 | Fischell | Mar 1994 | A |
5295970 | Clinton et al. | Mar 1994 | A |
5306253 | Brimhall | Apr 1994 | A |
5312355 | Lee | May 1994 | A |
5314411 | Bierman et al. | May 1994 | A |
5328480 | Melker et al. | Jul 1994 | A |
5330433 | Fonger et al. | Jul 1994 | A |
5334149 | Nortman et al. | Aug 1994 | A |
5334157 | Klein et al. | Aug 1994 | A |
5336191 | Davis et al. | Aug 1994 | A |
5342315 | Rowe et al. | Aug 1994 | A |
5366441 | Crawford | Nov 1994 | A |
5380290 | Makower et al. | Jan 1995 | A |
5388589 | Davis | Feb 1995 | A |
5391152 | Patterson | Feb 1995 | A |
5391178 | Yapor | Feb 1995 | A |
5397311 | Walker et al. | Mar 1995 | A |
5403283 | Luther | Apr 1995 | A |
5419766 | Chang et al. | May 1995 | A |
5425718 | Tay et al. | Jun 1995 | A |
5468024 | Carman et al. | Nov 1995 | A |
5512052 | Jesch | Apr 1996 | A |
5520654 | Wahlberg | May 1996 | A |
5531713 | Mastronardi et al. | Jul 1996 | A |
5542932 | Daugherty | Aug 1996 | A |
5578083 | Laguette et al. | Nov 1996 | A |
5589120 | Khan et al. | Dec 1996 | A |
5676653 | Taylor et al. | Oct 1997 | A |
5676658 | Erskine | Oct 1997 | A |
5676689 | Kensery et al. | Oct 1997 | A |
5685856 | Lehrer | Nov 1997 | A |
5688249 | Chang et al. | Nov 1997 | A |
5688570 | Ruttinger | Nov 1997 | A |
5690619 | Erskine | Nov 1997 | A |
5704914 | Stocking et al. | Jan 1998 | A |
5712229 | Hopkins et al. | Jan 1998 | A |
5713876 | Bogert | Feb 1998 | A |
5728132 | Van Tassel et al. | Mar 1998 | A |
5749857 | Cuppy | May 1998 | A |
5755693 | Walker et al. | May 1998 | A |
5795339 | Erskine | Aug 1998 | A |
5810780 | Brimhall et al. | Sep 1998 | A |
5820596 | Rosen et al. | Oct 1998 | A |
5820606 | Davis | Oct 1998 | A |
5827202 | Miraki et al. | Oct 1998 | A |
5830190 | Howell | Nov 1998 | A |
5833662 | Stevens | Nov 1998 | A |
5853393 | Bogert | Dec 1998 | A |
5858002 | Jesch | Jan 1999 | A |
5858007 | Fagan et al. | Jan 1999 | A |
5873854 | Wolvek | Feb 1999 | A |
5885217 | Gisselberg et al. | Mar 1999 | A |
5885253 | Liu | Mar 1999 | A |
5902254 | Magram | May 1999 | A |
5904657 | Unsworth et al. | May 1999 | A |
5910132 | Schultz | Jun 1999 | A |
5919160 | Sanfilippo | Jul 1999 | A |
5935110 | Brimhall | Aug 1999 | A |
5951518 | Licata et al. | Sep 1999 | A |
5954708 | Lopez et al. | Sep 1999 | A |
5957894 | Kerwin et al. | Sep 1999 | A |
5984895 | Padilla et al. | Nov 1999 | A |
6004294 | Brimhall et al. | Dec 1999 | A |
6027480 | Davis et al. | Feb 2000 | A |
6046143 | Khan et al. | Apr 2000 | A |
6074377 | Sanfilippo | Jun 2000 | A |
6080141 | Castro et al. | Jun 2000 | A |
6080520 | Polykarpov et al. | Jun 2000 | A |
6083207 | Heck | Jul 2000 | A |
6117108 | Woehr et al. | Sep 2000 | A |
6117140 | Munsinger | Sep 2000 | A |
6120494 | Jonkman | Sep 2000 | A |
6137468 | Martinez et al. | Oct 2000 | A |
6156010 | Kuracina et al. | Dec 2000 | A |
6159179 | Simonson | Dec 2000 | A |
6179813 | Barrow et al. | Jan 2001 | B1 |
6210366 | Sanfilippo | Apr 2001 | B1 |
6221050 | Ishida | Apr 2001 | B1 |
6245044 | Daw et al. | Jun 2001 | B1 |
6273871 | Davis et al. | Aug 2001 | B1 |
6277100 | Raulerson | Aug 2001 | B1 |
6287278 | Woehr et al. | Sep 2001 | B1 |
6287322 | Zhu et al. | Sep 2001 | B1 |
6328717 | Solomon et al. | Dec 2001 | B1 |
6336914 | Gillsespie, III | Jan 2002 | B1 |
6436070 | Botich et al. | Aug 2002 | B1 |
6461362 | Halseth et al. | Oct 2002 | B1 |
6475207 | Maginot | Nov 2002 | B1 |
6488662 | Sirimanne | Dec 2002 | B2 |
6500152 | Illi | Dec 2002 | B1 |
6524277 | Chang | Feb 2003 | B1 |
6567101 | Thomas | May 2003 | B1 |
6569120 | Green et al. | May 2003 | B1 |
6602240 | Hermann et al. | Aug 2003 | B2 |
6607511 | Halseth et al. | Aug 2003 | B2 |
6607353 | Masutani | Sep 2003 | B2 |
6626868 | Prestidge et al. | Sep 2003 | B1 |
6641564 | Kraus | Nov 2003 | B1 |
6692462 | Mackenzie et al. | Feb 2004 | B2 |
6692482 | Heller et al. | Feb 2004 | B2 |
6695816 | Cassidy | Feb 2004 | B2 |
6712789 | Lange et al. | Mar 2004 | B1 |
6714809 | Lee et al. | Mar 2004 | B2 |
6719722 | Trask et al. | Apr 2004 | B1 |
6726659 | Stocking et al. | Apr 2004 | B1 |
6783516 | O'Heeron et al. | Aug 2004 | B2 |
6786875 | Barker et al. | Sep 2004 | B2 |
6836687 | Kelley | Dec 2004 | B2 |
6905481 | Sirimanne | Jun 2005 | B2 |
6940092 | Yoshida et al. | Sep 2005 | B2 |
6942671 | Smith | Sep 2005 | B1 |
6972002 | Thorne | Dec 2005 | B2 |
6994693 | Tal | Feb 2006 | B2 |
7001396 | Glazier et al. | Feb 2006 | B2 |
7025746 | Tal | Apr 2006 | B2 |
7083626 | Hart et al. | Aug 2006 | B2 |
7101353 | Lui et al. | Sep 2006 | B2 |
7109967 | Hioki et al. | Sep 2006 | B2 |
7163525 | Franer | Jan 2007 | B2 |
7182755 | Tal | Feb 2007 | B2 |
7192433 | Osypka et al. | Mar 2007 | B2 |
7196689 | Moriyama | Mar 2007 | B2 |
7226434 | Carlyon et al. | Jun 2007 | B2 |
7270649 | Fitzgerald | Sep 2007 | B2 |
7455660 | Schweikert et al. | Nov 2008 | B2 |
7500965 | Menzi et al. | Mar 2009 | B2 |
7503596 | Rome et al. | Mar 2009 | B2 |
7556617 | Voorhees, Jr. et al. | Jul 2009 | B2 |
7614123 | Schweikert | Nov 2009 | B2 |
7670316 | Windheuser et al. | Mar 2010 | B2 |
7682339 | Fuji | Mar 2010 | B2 |
7717878 | Smith | May 2010 | B2 |
7722567 | Tal | May 2010 | B2 |
7744569 | Smith | Jun 2010 | B2 |
7827656 | Schweikert | Nov 2010 | B2 |
7833202 | Suzuki | Nov 2010 | B2 |
7922696 | Tal et al. | Apr 2011 | B2 |
7972307 | Kraus et al. | Jul 2011 | B2 |
7993305 | Ye et al. | Aug 2011 | B2 |
8021338 | Adams | Sep 2011 | B2 |
8070750 | Wenstrom, Jr. et al. | Dec 2011 | B2 |
3105288 | Keyser et al. | Jan 2012 | A1 |
8105286 | Anderson et al. | Jan 2012 | B2 |
8192402 | Anderson et al. | Jun 2012 | B2 |
8202251 | Bierman et al. | Jun 2012 | B2 |
8211087 | Carter et al. | Jul 2012 | B2 |
8377006 | Tal et al. | Feb 2013 | B2 |
8545833 | Spenser et al. | Oct 2013 | B2 |
8628497 | Finnestad et al. | Jan 2014 | B2 |
8657790 | Tal et al. | Feb 2014 | B2 |
8672888 | Tal | Mar 2014 | B2 |
8827958 | Bierman et al. | Sep 2014 | B2 |
8900192 | Anderson et al. | Dec 2014 | B2 |
8915884 | Tal et al. | Dec 2014 | B2 |
8956327 | Bierman | Feb 2015 | B2 |
9375553 | Chrisman | Jun 2016 | B2 |
9402979 | Alokaili et al. | Aug 2016 | B2 |
9764117 | Bierman et al. | Sep 2017 | B2 |
10010373 | Bierman et al. | Jul 2018 | B2 |
10136916 | Bierman | Nov 2018 | B2 |
10849651 | Bierman | Dec 2020 | B2 |
20020010436 | Becker et al. | Jan 2002 | A1 |
20020072712 | Nool et al. | Mar 2002 | A1 |
20020087076 | Megureo et al. | Jul 2002 | A1 |
20030032927 | Halseth et al. | Feb 2003 | A1 |
20030060842 | Chin et al. | Mar 2003 | A1 |
20030171718 | Delegge | Sep 2003 | A1 |
20030199827 | Thorne | Oct 2003 | A1 |
20030216771 | Osypka et al. | Nov 2003 | A1 |
20040008191 | Poupyrev et al. | Jan 2004 | A1 |
20040092879 | Kraus et al. | May 2004 | A1 |
20040102789 | Baughman | May 2004 | A1 |
20040167439 | Sharrow | Aug 2004 | A1 |
20040171988 | Moretti | Sep 2004 | A1 |
20040193112 | Glazier et al. | Sep 2004 | A1 |
20040199197 | Eidenschink et al. | Oct 2004 | A1 |
20040237202 | Potter | Dec 2004 | A1 |
20040239687 | Idesawa et al. | Dec 2004 | A1 |
20050027263 | Woehr et al. | Feb 2005 | A1 |
20050090835 | Deal et al. | Apr 2005 | A1 |
20050113798 | Slater et al. | May 2005 | A1 |
20050143770 | Carter et al. | Jun 2005 | A1 |
20050245875 | Restelli et al. | Nov 2005 | A1 |
20060015039 | Cassidy et al. | Jan 2006 | A1 |
20060015071 | Fitzgerald | Jan 2006 | A1 |
20060149293 | King et al. | Jul 2006 | A1 |
20060274036 | Hoiki et al. | Dec 2006 | A1 |
20070021685 | Oepen et al. | Jan 2007 | A1 |
20070060889 | Adams | Mar 2007 | A1 |
20070112302 | Yu | May 2007 | A1 |
20070123825 | King et al. | May 2007 | A1 |
20070161908 | Goldman et al. | Jul 2007 | A1 |
20070270751 | Stangenes et al. | Nov 2007 | A1 |
20070282300 | Attawia et al. | Dec 2007 | A1 |
20080004569 | McCrystle et al. | Jan 2008 | A1 |
20080097386 | Osypka | Apr 2008 | A1 |
20080234728 | Starkksen | Sep 2008 | A1 |
20080262430 | Anderson et al. | Oct 2008 | A1 |
20080262431 | Anderson et al. | Oct 2008 | A1 |
20080294111 | Tal et al. | Nov 2008 | A1 |
20090018508 | Fisher et al. | Jan 2009 | A1 |
20090036843 | Erskine | Feb 2009 | A1 |
20090143737 | Kobayashi et al. | Jun 2009 | A1 |
20090149857 | Culbert et al. | Jun 2009 | A1 |
20090163861 | Carlyon | Jun 2009 | A1 |
20090177163 | King et al. | Jul 2009 | A1 |
20090221961 | Tal et al. | Sep 2009 | A1 |
20090227843 | Smith et al. | Sep 2009 | A1 |
20090259186 | Smith et al. | Oct 2009 | A1 |
20090264867 | Schweikert et al. | Oct 2009 | A1 |
20090312786 | Trask et al. | Dec 2009 | A1 |
20100042049 | Eeflang et al. | Feb 2010 | A1 |
20100191189 | Harding et al. | Jul 2010 | A1 |
20100256567 | Smith | Oct 2010 | A1 |
20110021944 | Anderson et al. | Jan 2011 | A1 |
20110021994 | Anderson | Jan 2011 | A1 |
20110046564 | Zhong | Feb 2011 | A1 |
20110202006 | Bierman et al. | Aug 2011 | A1 |
20110218496 | Bierman | Sep 2011 | A1 |
20110276002 | Bierman | Nov 2011 | A1 |
20120004665 | Defossez et al. | Jan 2012 | A1 |
20120065590 | Bierman et al. | Mar 2012 | A1 |
20120130307 | Pobitschka | May 2012 | A1 |
20120136308 | Racz | May 2012 | A1 |
20120179144 | Carleo | Jul 2012 | A1 |
20120283640 | Bierman et al. | Nov 2012 | A1 |
20120316500 | Bierman et al. | Dec 2012 | A1 |
20140025036 | Bierman et al. | Jan 2014 | A1 |
20140081210 | Bierman et al. | Mar 2014 | A1 |
20140207069 | Bierman et al. | Jul 2014 | A1 |
20140221977 | Belson | Aug 2014 | A1 |
20150126930 | Bierman et al. | May 2015 | A1 |
20150190168 | Bierman et al. | Jul 2015 | A1 |
20150297868 | Tal et al. | Oct 2015 | A1 |
20170035459 | Bierman et al. | Feb 2017 | A1 |
20170291009 | Sos | Oct 2017 | A1 |
20180001060 | Bierman et al. | Jan 2018 | A1 |
Number | Date | Country |
---|---|---|
2052364 | Apr 1972 | DE |
8915299 | Feb 1990 | DE |
8914941 | Sep 1990 | DE |
20211804 | Jan 2003 | DE |
0129745 | Jan 1985 | EP |
0139091 | May 1985 | EP |
0352928 | Jan 1990 | EP |
0411605 | Feb 1991 | EP |
0583144 | Feb 1994 | EP |
0502714 | Nov 1995 | EP |
0904023 | Mar 1999 | EP |
1570793 | Sep 2005 | EP |
2368968 | May 1978 | FR |
53051692 | May 1978 | JP |
06285172 | Oct 1994 | JP |
07148270 | Jun 1995 | JP |
08336593 | Dec 1996 | JP |
11299897 | Nov 1999 | JP |
2001190682 | Jul 2001 | JP |
2002172174 | Jun 2002 | JP |
2003512903 | Apr 2003 | JP |
2003-154013 | May 2003 | JP |
2003154013 | May 2003 | JP |
2004500218 | Jan 2004 | JP |
200497843 | Apr 2004 | JP |
2005514114 | May 2005 | JP |
2007503172 | Feb 2007 | JP |
2007209721 | Aug 2007 | JP |
2010504295 | Feb 2010 | JP |
1020050027359 | Mar 2005 | KR |
8301575 | May 1983 | WO |
8807388 | Oct 1988 | WO |
9218193 | Oct 1992 | WO |
9311812 | Jun 1993 | WO |
9312826 | Jul 1993 | WO |
9412233 | Jun 1994 | WO |
9804189 | Feb 1998 | WO |
98024494 | Jun 1998 | WO |
9857685 | Dec 1998 | WO |
0000104 | Jan 2000 | WO |
0123028 | Apr 2001 | WO |
01024865 | Apr 2001 | WO |
0141860 | Jun 2001 | WO |
0178595 | Oct 2001 | WO |
03041598 | May 2003 | WO |
03057272 | Jul 2003 | WO |
2004000407 | Dec 2003 | WO |
06119503 | Nov 2006 | WO |
08064332 | May 2008 | WO |
08131300 | Sep 2009 | WO |
2009114833 | Sep 2009 | WO |
11162866 | Dec 2011 | WO |
2012117028 | Sep 2012 | WO |
12135761 | Oct 2012 | WO |
2012162677 | Nov 2012 | WO |
13026045 | Feb 2013 | WO |
2013026045 | Feb 2013 | WO |
Entry |
---|
Exam Report received in Application No. EP 11740538 dated Sep. 22, 2014. |
International Preliminary Report on Patentability received in Application No. PCT/US2011/024097 dated Aug. 14, 2012. |
Photograph of various access devices. |
Photos of a peripheral emergency infusion device Applicant believes to be produced by Arrow International Inc., Jul. 20, 2011. |
Photos of a splittable catheter design, Jul. 20, 2011. |
Photos of an infusion device Applicant believes to be produced by B. Braun Medical Inc., Jul. 20, 2011. |
Supplementary European Search Report received in Application No. EP 11740538 dated Sep. 10, 2013. |
Arrow Trauma Products No. TRM-C 12/00 11 M, Arrow International, dated 2000. |
International Search Report and Written Opinion, PCT/US2011/024097, dated Oct. 25, 2011. |
Number | Date | Country | |
---|---|---|---|
20210038252 A1 | Feb 2021 | US |
Number | Date | Country | |
---|---|---|---|
61302486 | Feb 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14589702 | Jan 2015 | US |
Child | 16191122 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16191122 | Nov 2018 | US |
Child | 17082566 | US | |
Parent | 13577653 | US | |
Child | 14589702 | US |